Diabetes

Patients with chronic conditions who receive care from pharmacists may be more likely to reach their blood glucose, blood pressure, and cholesterol goals.

Diabetes costs the United States more than $300 billion annually, so concerted efforts are needed to manage this disease.

Study highlights importance of a healthy lifestyle in patients with diabetes.

Diabetes has the dubious distinction of being the 7th leading cause of death and the leading cause of kidney failure, non-traumatic lower-limb amputations, and blindness in the United States.

Pharmacy benefit manager releases data showing the cost of insulin grew by 8%.

TZD-based medicines effectively improve glucose uptake.

Metformin has been found the most effective type 2 diabetes drug.

By 2014, 8.5% of the global population had diabetes.

Neighborhoods with greater resources for healthy diets and physical activity may be associated with lower risk for type 2 diabetes.

The number of adults living with diabetes worldwide has nearly quadrupled from 108 million in 1980 to 422 million in 2014.

This Continuing Education activity is supported by an educational grant from Novo Nordisk.

Improving insulin signaling in the brain may reduce the likelihood patients with Alzheimer's disease develop diabetes.

Pharmacists can aggressively intervene to adjust medications when patients’ diabetes is uncontrolled.

Did you know that diabetes is a common problem in prisons?

Multifaceted interventions with multiple members of the diabetes patient care team found more effective.

Inhibiting newly classified enzymes may lead to treatments for type 2 diabetes, inflammation, and autoimmune disease.

Program leads to estimated Medicare savings of $2650 for each enrollee over a 15-month period.

As the diabetic population continues to swell, diabetes care has shifted from being the purview of strictly endocrinologists to a focus for all health care providers.

New insulin caused blood sugar levels to fall in mouse models, creating hope for improved treatment of diabetes.

The experimental drug CMX-2043 protected heart muscle from stenting but it has shown no increased protection in kidneys.

Concerns raised regarding a three-fold rise in the cost of insulin as other diabetes drugs remained stable.

People from poor or middle-income households with conditions such as diabetes or asthma face greater risk for serious mental illness.

People with difficulty repairing damaged DNA develop diabetes more rapidly when beta cells are met with cellular stress.

All diabetic neuropathies increase risk of all-cause death and adversely affect quality of life.

The FDA has announced that it is updating the labels of several type 2 diabetes medications to warn patients and providers of an increased heart failure risk associated with the drugs' use.